Intensification of androgen deprivation therapy in metastatic hormone-sensitive prostate cancer: patient selection and overview of doublet and triplet therapy data.
Publication
, Chapter
Shevach, JW; Park, JJ; Armstrong, AJ
May 2024
Duke Scholars
Citation
APA
Chicago
ICMJE
MLA
NLM
Shevach, J. W., Park, J. J., & Armstrong, A. J. (2024). Intensification of androgen deprivation therapy in metastatic hormone-sensitive prostate cancer: patient selection and overview of doublet and triplet therapy data. (Vol. 4, pp. 185–198). https://doi.org/10.1016/j.yao.2023.12.006
Shevach, Jeffrey W., Joseph J. Park, and Andrew J. Armstrong. “Intensification of androgen deprivation therapy in metastatic hormone-sensitive prostate cancer: patient selection and overview of doublet and triplet therapy data.,” 4:185–98, 2024. https://doi.org/10.1016/j.yao.2023.12.006.
Shevach JW, Park JJ, Armstrong AJ. Intensification of androgen deprivation therapy in metastatic hormone-sensitive prostate cancer: patient selection and overview of doublet and triplet therapy data. In 2024. p. 185–98.
Shevach, Jeffrey W., et al. Intensification of androgen deprivation therapy in metastatic hormone-sensitive prostate cancer: patient selection and overview of doublet and triplet therapy data. Vol. 4, 2024, pp. 185–98. Pubmed, doi:10.1016/j.yao.2023.12.006.
Shevach JW, Park JJ, Armstrong AJ. Intensification of androgen deprivation therapy in metastatic hormone-sensitive prostate cancer: patient selection and overview of doublet and triplet therapy data. 2024. p. 185–198.